The TRACK (Therapeutic and Regulatory Science Advancement in Congenital Kidney Disease) Consortium is a KidneyFuture Foundation convened, multi-stakeholder effort focused on advancing trial-enabling regulatory science for congenital kidney disease, including CAKUT and related conditions.
The consortium brings together patients and families, clinicians, researchers, registries, industry, and regulators to clarify natural history, distinguish evidence from uncertainty, and develop shared frameworks to support future therapeutic development in a transparent, pre-competitive manner.

Regulatory Science.
Congenital kidney disease is a leading cause of chronic kidney disease in children and young adults, yet therapeutic development has been limited by disease heterogeneity, incomplete natural history, and uncertainty around endpoints and trial design.
The CKD-TRC exists to address these barriers by aligning stakeholders around shared evidence, identifying gaps, and supporting the development of trial-enabling tools that can responsibly accelerate progress.
Patients, clinicians, researchers, registries, industry, and regulators engaged as scientific contributors.
Built around the Congenital Kidney Disease Trial Readiness Summit and focused follow-on workstreams.
Informed by U.S. and international cohorts, research networks, and clinical experience.
Enable safe, effective therapeutic development for congenital kidney disease.
KidneyFuture convened the TRACK Consortium in response to a clear need voiced by families, clinicians, and researchers. Families affected by congenital kidney disease still face uncertainty, limited treatment options, and few clinical trials designed for their conditions.
By convening the community around shared questions and evidence, the consortium aims to move the field from observation toward action, while centering patient experience and long-term outcomes.

We focus on clarity, not consensus. The consortium highlights what is known, what is uncertain, and where further work is needed to responsibly advance trials.
Patient and caregiver perspectives help shape priorities, endpoints, and definitions of meaningful benefit.

The TRACK Consortium is informed by leading experts in nephrology, congenital kidney disease, trial design, and regulatory science. Scientific discussions emphasize rigor, transparency, and alignment with regulatory expectations.
KidneyFuture serves as the coordinating organization. Participation is voluntary, project-based, and non-exclusive.
Discussions are informed by clinical evidence, real-world data, and lived experience.
The consortium focuses on shared challenges that no single organization can address alone.
Workstreams aim to bridge natural history, biology, and trial design considerations.
Meeting summaries and high-level frameworks are shared publicly to benefit the broader community.
Ensuring lived experience and patient priorities inform all discussions
Addressing the unique needs of children with kidney disease
Advancing clinical research, translational science, and innovation
Enabling collaboration, data sharing, and multi-site studies
Developing therapies and technologies for kidney disease
Contributing scientific perspective on regulatory science
The CKD-TRC is convened and coordinated by KidneyFuture, a patient- and parent-led nonprofit dedicated to improving outcomes for families affected by congenital kidney disease.
Scientific activities are guided by a small planning group of patient representatives and subject-matter experts. Governance and structure may evolve as activities progress.
(No formal membership, fees, or institutional commitments are required.)

Lead Therapist

Support Coordinator

Counseling Specialist

Wellness Coach

Lead Therapist

Support Coordinator

Counseling Specialist

Wellness Coach
This upcoming meeting convenes clinicians, researchers, patient representatives, data partners, industry, and regulators to advance shared understanding of congenital kidney disease and align on evidence needed to support future trial readiness.
The summit serves as a foundational convening for the Congenital Kidney Disease Trial Readiness Consortium, informing ongoing collaboration and follow-on workstreams.


"I was struggling with my mental health for a long time, but the team at this clinic provided me with the support I needed every step of the way. Their therapy and counseling sessions have truly transformed my life. Today, I feel more confident and at peace with myself. The care and expertise they offer are beyond words."

Graphic Designer


"The therapists at this clinic gave me a safe and understanding space to talk about my mental health challenges. Their professional approach and deep empathy made me feel heard and supported. With their guidance, I’ve been able to make real progress. I’m learning how to manage my emotions and live a more balanced life."

Marketing Manager


"I was searching for a trusted place to address my mental health concerns, and this clinic provided exactly what I needed. The team’s caring and professional approach made me feel comfortable and encouraged throughout my journey. They’ve helped me understand myself better and develop healthier coping mechanisms."

Marketing Manager

We specialize in providing comprehensive mental health services designed to help you understand, manage, and improve your emotional and psychological well-being. Using evidence-based therapies and personalized care plans


The Congenital Kidney Disease Trial Readiness Consortium is convened by KidneyFuture. Participation by external organizations and individuals does not imply endorsement. Engagement by government agencies occurs in accordance with applicable policies and procedures.
© KidneyFuture. 2026. All Rights Reserved.